The EmCell Cell Therapy Center in Kyiv, Ukraine offers diabetes mellitus treatment using fetal stem cells. The treatment may cost around $6,000 USD for adults with Type 1 diabetes. The clinic pioneered fetal stem cell therapy and has 30 years of specialized experience.
The procedure uses fetal stem cells and pancreatic beta-cell precursors. These cells are administered through intravenous or subcutaneous injections. The therapy aims to improve pancreatic function in diabetic patients.
The EmCell team has developed patented stem cell protocols. They were the world's first fetal stem cell therapy center. The multidisciplinary team includes endocrinology and regenerative medicine specialists.
Patients typically stay 2-3 days in Kyiv. The center provides interpreter services and follow-up monitoring. A premium 2-day treatment course is also available for $12,000 USD.
Consider contacting the clinic to discuss treatment options for diabetes management.
Programma di trattamento individuale e preventivo
Tempo medio di risposta — 5 minuti
| trattamento | Prezzo | |
|---|---|---|
| Diabetes mellitus treatment with stem cells | Prezzo su richiesta | |
| Stem cell for diabetes | Prezzo su richiesta |
EmCell is recognized as the world’s first clinic to specialize in fetal stem cell therapy. With more than 30 years of clinical experience, the center has developed effective treatment protocols for conditions such as autism, diabetes, neurodegenerative disorders, and anti-aging. It began its work with treating aplastic anemia and continues expanding its expertise in regenerative medicine.
EmCell’s clinical department is led by medical doctors who were instrumental in developing the clinic’s patented fetal stem cell therapy. The team includes experienced neurologists, cardiologists, and general physicians, supported by skilled nurses and assistants. Comprehensive diagnostic evaluations—including ultrasound, ECG, EchoCG, Doppler studies, spirography, and densitometry—are conducted before treatment, followed by careful post-treatment monitoring to ensure safety and effectiveness.
The laboratory complex features a GMP-compliant Biotechnological Laboratory where fetal stem cell preparations are created using proprietary techniques. These preparations serve as the foundation of EmCell’s therapeutic programs. The department rigorously tests all materials throughout each stage, from donor screening to final release, to meet strict quality standards.
The PCR Laboratory performs real-time polymerase chain reaction testing to detect viral and bacterial pathogens such as HIV, HCV, HBV, CMV, HPV, and COVID-19, ensuring the safety of stem cell materials. EmCell also operates an ISO 15189-accredited Clinical-Diagnostic Laboratory offering a wide range of tests, including immunophenotyping, biochemical analysis, cytology, and hormone profiling.
The clinic maintains a cryobank housing over 20,000 live fetal stem cell samples preserved through advanced cryopreservation methods. This resource enables personalized treatment approaches and supports consistent clinical outcomes.
EmCell’s R&D division is dedicated to improving the efficacy of fetal stem cell therapies and expanding treatment options through continuous innovation and product development.
The clinic provides comprehensive patient support throughout the treatment journey. Each treatment package includes pick-up services from train or bus stations in Kyiv, daily transfers between the hotel and clinic, and interpreter support to facilitate clear communication with the medical team. Patients also undergo a series of examinations, such as abdominal and thyroid ultrasounds, ECG, and laboratory tests.
Following treatment, EmCell maintains long-term communication with each patient. A dedicated follow-up manager and the treating physician remain available to answer questions, provide additional recommendations, and track post-treatment progress.
Programma di trattamento individuale e preventivo
Tempo medio di risposta — 5 minuti